Review Of The Drug Enforcement Administration's (DEA) Control Of The Diversion Of Controlled Pharmaceuticals
- NARA ID
- review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Source
- oig-doj
- Collection
- DOJ OIG — Other
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2002-09-01
- Slug
- doj-oig-review-drug-enforcement-administrations-dea-control-diversion-controlled-pharmaceuticals
- Indexed
- 2026-04-27 05:13:58
More from DOJ OIG — Other
- Federal Bureau of Prisons Annual Financial Statement Fiscal Year 2000
- Audit of Drug Court and Technical Assistance Project Grants Administered by the Justice Management Institute, Denver, Colorado
- Newark, New Jersey Police Department
- Immigration and Naturalization Service Management of Property
- Immigration and Naturalization Service Collection of Fees at Land Border Ports of Entry
- Investigative Summary: Findings of Misconduct by an FBI Senior Executive for Violating Federal Conflict of Interest Rules, Failure to Report Source of Spouse's Income, and Related Misconduct
About the DOJ OIG — Other collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning this DOJ component.